0001127602-17-012973.txt : 20170327 0001127602-17-012973.hdr.sgml : 20170327 20170327173229 ACCESSION NUMBER: 0001127602-17-012973 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170323 FILED AS OF DATE: 20170327 DATE AS OF CHANGE: 20170327 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cooke Shane CENTRAL INDEX KEY: 0001524823 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 17716267 MAIL ADDRESS: STREET 1: TREASURY BUILDING LOWER GRAND CANAL ST. CITY: DUBLIN 2 STATE: L2 ZIP: 00000 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2017-03-23 0001520262 Alkermes plc. ALKS 0001524823 Cooke Shane CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 IRELAND 1 President, Alkermes plc Ordinary Shares 2017-03-23 4 M 0 3000 14.60 A 74948 D Ordinary Shares 2017-03-23 4 M 0 3030 16.55 A 77978 D Ordinary Shares 2017-03-23 4 S 0 6030 60.0093 D 71948 D Employee Stock Option (Right to Buy) 14.60 2017-03-23 4 M 0 3000 0 D 2021-10-05 Ordinary Shares 3000 200 D Employee Stock Option (Right to Buy) 16.55 2017-03-23 4 M 0 3030 0 D 2022-05-21 Ordinary Shares 3030 155870 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. These options are fully vested in accordance with their terms. /s/ Jennifer Baptiste, attorney-in-fact for Shane Cooke 2017-03-27